Legochem Biosciences contracted technology transfer of antibiotic to AstraZeneca
(Yakup Shinmoon)
On Jan 14, Legochem Biosciences announced that they made a contract of 'Gram-negative antibiotic (LCB10-0200) candidate substance' technology transfer to AstraZeneca.
According to the company, the contract includes technology transfer of right to use 'LCB10-0200' for mon...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
